Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
The current outbreak of severe acute respiratory distress syndrome (SARS) or nCOVID-19 pandemic, caused by the coronavirus-2 (CoV-2), continues to wreak havoc globally. As novel vaccines are being discovered and developed, small molecule drugs still constitute a viable treatment option for SARS-CoV-...
Main Authors: | Praveen P. N. Rao, Amy Trinh Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, Ahmed A. Hefny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/1/44 |
Similar Items
-
Anticoagulants as Potential SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
by: Ayman Abo Elmaaty, et al.
Published: (2022-10-01) -
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M<sup>pro</sup>
by: Andrea Citarella, et al.
Published: (2023-01-01) -
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M<sup>pro</sup> and PL<sup>pro</sup> of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations
by: Devashan Naidoo, et al.
Published: (2021-08-01) -
Fluorine Atoms on C<sub>6</sub>H<sub>5</sub>-Corrole Affect the Interaction with M<sup>pro</sup> and PL<sup>pro</sup> Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
by: Otávio Augusto Chaves, et al.
Published: (2022-09-01) -
Development of Masitinib Derivatives with Enhanced M<sup>pro</sup> Ligand Efficiency and Reduced Cytotoxicity
by: Cintia A. Menendez, et al.
Published: (2023-09-01)